Terminated PHASE3 INTERVENTIONAL 3-arm NCT01849965

Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers (STRIDE 2)

A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects With Diabetes Mellitus

Sponsor: Integra LifeSciences Corporation

Conditions Diabetic Foot Ulcers

Interventions DSC127 Standard of Care gel, Aquasite placebo vehicle gel

Updated 9 times since 2017 Last updated: Dec 8, 2017 Started: Apr 30, 2013 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Integra LifeSciences Corporation

More terminations from Integra LifeSciences Corporation

Other Diabetic Foot Ulcers trials with similar outcome

Browse all Diabetic Foot Ulcers trials

This PHASE3 trial investigates Diabetic Foot Ulcers and is currently terminated or withdrawn. Integra LifeSciences Corporation leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 4 earlier versions

Dec 2017 — Jun 2018 [monthly]

Terminated PHASE3

Status: Unknown Status → Terminated
Jul 2017 — Dec 2017 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Feb 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Integra LifeSciences Corporation
Integrium

Data source: Integra LifeSciences Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aguadilla, Puerto Rico , Benoni, South Africa , Bloemfontein, South Africa , Boucherville, Canada , Boynton Beach, United States , Cape Town, South Africa , Castro Valley, United States , Chino, United States , Dallas, United States , Denver, United States and 37 more locations